Researchers said that a common treatment for prostate cancer may slightly increase patient's risk of heart problems. Experts said the findings could make doctors think twice before prescribing the standard hormone treatment to men with prostate cancer, particularly if they are at risk of heart disease
More than 670,000 men are diagnosed with prostate cancer globally every year, making it the second-most common cancer in men after lung cancer.
In the U.S. about 600,000 men are being treated with endoc rine therapy for prostate cancer. Prostate cancer patients had a 28% higher relative chance of having a final heart attack and a 21% increased chance of dying from heart disease. Still these risks were low in absolute terms; researchers estimated the hormone therapy would cause an extra 10 heart problems - like chest pain or a heart attack a year for every 1,000 prostate cancer patients.
Be aware, previous studies have found hormone therapy given to prostate cancer patient with a history of heart disease increased their chances of dying.
No comments:
Post a Comment